Refine your search
Collections
Co-Authors
Journals
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Patil, Poonam
- Persistence of Chikungunya Virus in Samples Stored at Different Temperatures
Abstract Views :497 |
PDF Views:86
Authors
Deepti Parashar
1,
A. B. Sudeep
1,
Ashwini More
1,
Poonam Patil
1,
Atul Walimbe
1,
Mangala Mavale
1,
Sarika Amdekar
1
Affiliations
1 ICMR-National Institute of Virology, 20A, Ambedkar Road, Pune 411 001, IN
1 ICMR-National Institute of Virology, 20A, Ambedkar Road, Pune 411 001, IN
Source
Current Science, Vol 115, No 1 (2018), Pagination: 25-27Abstract
Chikungunya virus (CHIKV), a mosquito-borne alphavirus (family Togaviridae), has become a globally major public health problem since 2004 (ref. 1). No vaccines or therapeutics are available except for mosquito control. CHIKV is relatively stable in blood at room temperature and remains viable for at least 8 h (ref. 2). However, no documented data is available regarding survival of CHIKV outside the host, i.e. in serum or infected mosquitoes. Understanding the survival and environmental stability of CHIKV in the above samples is important for effective management during outbreaks and handling clinical samples.Full Text
References
- Peterson, L. R. and Powers, A. M., Chikungunya: epidemiology. F1000Res (2016); 5. pii: F1000 Faculty Rev-82. doi:10.12688/f1000research.7171.1.eCollection 2016.
- Ramachandrarao, T., Sharda Devi, P. and Singh, K. R., Mosq. News, 1968, 28, 406–408.
- Sudeep, A. B., Ghodke, Y. S., Gokhale, M. D., George, R. P., Dhaigude, S. D. and Bondre, V. P., J. Vector Borne Dis., 2014, 51, 333–338.
- Reed, L. J. and Muench, H. A., Am. J. Hyg., 1938, 27, 493–497.
- Parashar, D., Amdekar, S., More, A., More, R., Patil, P. and Ravindra Babu, V., Indian J. Med. Res. (Supplement), 2015, 142, 62–66.
- Parashar, D., Paingankar, M. S., Sudeep, A. B., More, A., Shinde, S. and Arankalle, V. A., Curr. Sci., 2014, 107, 211–213.
- Parashar, D., Paingankar, M. S., Kumar, S., Gokhale, M. D., Sudeep, A. B., Shinde, S. B. and Arankalle, V. A., PLoS Negl. Trop. Dis., 2013, 7, e2405.
- Mavale, M. et al., Am. J. Trop. Med. Hyg., 2012, 86, 178–180.
- Damjanovic, V., J. Hosp. Infect., 1987, 10, 209–211.
- Dimmock, N. J., Virology, 1967, 31, 338–353.
- Salvucci, J. T., Cell Tissue Bank, 2011, 12, 99–104.
- Bean, B., Moore, B. M., Sterner, B., Peterson, L. R., Gerding, D. N. and Balfour Jr, H. H., J. Infect. Dis., 1982, 146, 47–51.
- Sebire, K., McGavin, K., Land, S., Middleton, T. and Birch, C., J. Clin. Microbiol., 1998, 36, 493–498.
- Tjotta, E., Hungnes, O. and Grinde, B., J. Med. Virol., 1991, 35, 223–227.
- Paintsil, E., Binka, M., Patel, A., Lindenbach, B. D. and Heimer, R., J. Infect. Dis., 2014, 209, 1205–1211.
- Detmer, J. et al., J. Clin. Microbiol., 1996, 34, 901–907.
- Effectiveness of TMJ Mulligan Mobilization in Individuals with Trismus
Abstract Views :626 |
PDF Views:0
Authors
Affiliations
1 Krishna Institute of medical Sciences Deemed to be University, Karad, Maharashtra, IN
2 Department of Cardio Pulmonary, Krishna Institute of medical Sciences Deemed to be University, Karad, Maharashtra, IN
1 Krishna Institute of medical Sciences Deemed to be University, Karad, Maharashtra, IN
2 Department of Cardio Pulmonary, Krishna Institute of medical Sciences Deemed to be University, Karad, Maharashtra, IN
Source
Indian Journal of Public Health Research & Development, Vol 10, No 12 (2019), Pagination: 460-463Abstract
Objectives: To find out the effect of mulligan mobilization in individuals with trismus.
Method: Ethical Clearance was obtained from institutional ethical committee. A total 30 subjects with trismus were selected and mulligan mobilization were given for 1 hour/day and 5days/week. The preassessment of ROM was measured by vernierecaliper and pain was measured on VAS and post interventional assessment was taken for the same after 10 days
Result: This study showed significant improvement in the outcome variables concluding that it increases ROM and decreases PAIN. This was confirmed using statistical analysis by using paired t test for within group comparison. ROM Post training there was extremely significant improvement noted with individuals with trismus. p value =<0.0001,VAS post training there was extremely significant improvement noted with trismus p value= <0.0001
Conclusion: Hence Mulligan mobilization is effective in improving ROM and it is also effective in decreasing pain in TRISMUS condition.
Keywords
Trismus, Physiotherapy, Mulligan Mobilization.
- Study of Placental Laterality as a Predictor for Development of Pre-Eclampsia at a Tertiary Care Centre
Abstract Views :128 |
PDF Views:78
Authors
Affiliations
1 Professor, Department of Obstetrics and Gynaecology, Dr. Vasantrao Pawar Medical College, Hospital and Research Centre, Vasantdada Nagar, Adgaon, Nashik – 422003, IN
2 Former PG Resident, Department of Obstetrics and Gynaecology, Dr. Vasantrao Pawar Medical College, Hospital and Research Centre, Vasantdada Nagar, Adgaon, Nashik – 422003, IN
3 Assistant Professor, Department of Obstetrics and Gynaecology, Dr. Vasantrao Pawar Medical College, Hospital and Research Centre, Vasantdada Nagar, Adgaon, Nashik – 422003, IN
1 Professor, Department of Obstetrics and Gynaecology, Dr. Vasantrao Pawar Medical College, Hospital and Research Centre, Vasantdada Nagar, Adgaon, Nashik – 422003, IN
2 Former PG Resident, Department of Obstetrics and Gynaecology, Dr. Vasantrao Pawar Medical College, Hospital and Research Centre, Vasantdada Nagar, Adgaon, Nashik – 422003, IN
3 Assistant Professor, Department of Obstetrics and Gynaecology, Dr. Vasantrao Pawar Medical College, Hospital and Research Centre, Vasantdada Nagar, Adgaon, Nashik – 422003, IN
Source
MVP Journal of Medical Sciences, Vol 8, No 1 (2021), Pagination: 132–139Abstract
Introduction: Hypertensive disorders of pregnancy is the commonest medical complication. Pre-eclampsia in India is reported to be 8-10%. Out of which hypertension in pregnancy was 7.8% with pre-eclampsia in 5.4%. India has the highest number of preterm births in the World. Hypertension in pregnancy (gestational hypertension – 4.8%, eclampsia – 4.8%, chronic hypertension – 5%, & pre-eclampsia – 36%) are the major risk factors of the preterm births in India. Aims and Objectives: To evaluate placental location (by ultrasound at 18-24 weeks) & its corelation in predicting development of pre-eclampsia. Methodology: This prospective study on 108 low risk antenatal women with ultrasonography with documented placental location. After determining the placental location (ultrasound scanning at 18 – 20 weeks) were classified into two groups. Women having central placenta in the central region were assigned to group A & women having lateral placenta to group B. All women were observed regularly during pregnancy up to delivery. Development of signs and symptoms of pre-eclampsia were looked for. Results in 2 groups were compared for statistical significance. Results: Laterally placed placenta showed higher Systolic BP and Diastolic BP as compared to centrally placed placenta at every GA. But 36-37 Gestational Age only provide statistically significant results. Conclusion: In the present study, 61.1% women who eventually developed pre-eclampsia had a lateral placenta while 37% women had a centrally placenta. Laterally placed placenta showed higher Systolic BP and Diastolic BP as compared to centrally placed placenta which provide statistically significant results.Keywords
DBP- Diastolic Blood Pressure, PE – Pre-Eclampsia, SBP – Systolic Blood PressureFull Text
References
- National health portal. Available at: https://www. nhp.gov.in/disease/gynaecology-and-obstetrics/ preeclampsia#:~:text=In%20India%2C%20the%20incidence% 20of,the%20study%20population%20in%20India*.
- Olson-Chen C, Seligman NS. Hypertensive Emergencies in Pregnancy. Crit Care Clin 2016; 32(1): 29–41.
- Cunningham FG, Leveno KJ, Bloom SL, et al. William’s obstetrics. 23rd edn. Chapter 34. Pregnancy induced hypertension. Access Medicine 2010: 706–50.
- American College of Obstetricians and Gynecologists. Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol 2013; 122(5): 1122–31.
- Agrawal S, Walia GK, Staines UE, Casas JP, Millett C. Prevalence of and risk factors for eclampsia in pregnant women in India. Family Med Com Health 2016; 5: 225– 244. https://doi.org/10.15212/FMCH.2016.0121
- Patil S, Patil KP. Analysis of risk factors of late preterm birth: a case-control study. Indian J Health Sci Biomed Res 2017; 10: 283–287. https://doi.org/10.4103/kleuhsj.ijhs_350_16
- Shivamurthy HM, Sharada KS, Giridhar SA, Himgire JR, Asaranna D. Placental laterality as a predictor of preeclampsia- An ultrasonic prospective study. J Pub Health Med Res 2014; 2(1): 38–40.
- Cunningham MW Jr, LaMarca BD. The Risk of Cardiovascular Disease, End-Stage Renal Disease, and Stroke in Post-Partum Women and their Fetuses after a Hypertensive Pregnancy. Am J Physiol Regul Integr Comp Physiol 2018. https://doi.org/10.1152/ajpregu.00218.2017
- Mayer-Pickel K, Stern C, Eberhard K, Lang U, Obermayer- Pietsch B, Cervar-Zivkovic M. Angiogenic factors in pregnancies of women with antiphospholipid syndrome and systemic lupus erythematosus. J Reprod Immunol 2018; 127: 19–23. https://doi.org/10.1016/j.jri.2018.04.002
- Fleischer A, Schulman H, Farmakides G et al. Uterine artery Doppler velocimetry in pregnant women with hypertension. Am J Obstet Gynecol 1986; 154(4): 806–13. https:// doi.org/10.1016/0002-9378(86)90462-X
- Magann EF, Doherty DA, Turner K, et al. Second trimester placental location as a predictor of an adverse pregnancy outcome. J Perinatol 2007; 27(1): 9–14. https://doi. org/10.1038/sj.jp.7211621
- Anuja VB, Sayali K, Savita S. Lateral placentation by ultrasonography: a simple predictor of preeclampsia. J South Asian Feder Obst Gynae 2013; 5(2): 68–71. https://doi. org/10.5005/jp-journals-10006-1227
- Salas SP. What causes pre-eclampsia? Baillieres Best Pract Res Clin Obstet Gynaecol 1999; 13(1): 41-57. https://doi. org/10.1053/beog.1999.0005
- Kore SJ, Khot R, Supe P, Kanavia D, Thunga C, Nandanwar Y. Prediction of pre-eclampsia: role of placental laterality by ultrasonography. Int J Reprod Contracept Obstet Gynecol 2016; 5: 1433–7. https://doi.org/10.18203/2320-1770.ijrcog20161300
- Jani PS, Patel UM, Gandhi MR, Thakor NC, Kakani CR. Placental laterality and uterine artery resistance as predictor of pre-eclampsia: a prospective study at GMERS Medical College, Dharpur-Patan, North Gujarat, India. Int J Res Med Sci 2015; 3: 1484–7. https://doi.org/10.18203/2320- 6012.ijrms20150172
- Yousuf S, Ahmad A, Qadir S, Gul S et al. Utility of placental laterality and uterine artery doppler abnormalities for prediction of pre-eclampsia. J Obstet Gynaecol India 2016; 6(S1): S212–S216. https://doi.org/10.1007/s13224-015- 0837-z
- Muralidhar PV, Pillai J. Placental laterality by ultrasonography as predictive marker for pre-eclampsia. J Obstet Gynaecol India; 2005; 55(5): 431–33.
- Vaillant P, Best MC, Cynober E, Devulder G. Pathological uterine readings when the placenta is laterally situated. J Gynecol Obstet Biol Reprod 1993; 22: 301–7.
- Kalanithi LE, Illuzzi JL, Nossov VB et al. Intrauterine growth restriction and placental location. J Ultrasound Med 2007; 26: 1481–9. https://doi.org/10.7863/jum.2007.26.11.1481
- Ahuja P, Saxena U. Role of Placental laterality as a Predictive Tool for Pre-eclampsia. Int. J. Contemp. Surg., Surgery. 2020; 8(1): 26–30.
- Aggarwal P, Kangjam P, Terhase N. Study on relation between placental laterality in second trimester ultrasound and development of pre-eclampsia at term. JEMDS 2015 (December 2015); 4(104): 16926–16928. https://doi. org/10.14260/jemds/2015/2550
- Sumathi N, Pavithra GR. Placental Laterality-A Simple yet reliable predictor of pre-eclampsia an ultrasonic prospective study. IOSR-JDMS 2016 (October 2016); 15(10): 116–121.
- Salama-Bello R, Jose R, Howard S, Song J, Schenone M. Placental location and the development of hypertensive disorders of pregnancy. Am In Ultra Med 2018; 38: 1–5. https://doi.org/10.1002/jum.14681
- Gupta A, Bansal P, Sen J, Singhal SR. Correlation of lateral placental location with development of pre-eclampsia. Int J Reprod Contracept Obstet Gynecol 2020; 9: 1017–22. https://doi.org/10.18203/2320-1770.ijrcog20200867
- Kakkar T, Singh V, Ranzdan R, Sanjeev KD, Gupta A, Kakkar M. Placental laterality as a predictor for development of pre-eclampsia. J Obstet Gynaecol 2012; 63: 22–5. https://doi.org/10.1007/s13224-012-0241-x
- Ambastha V, Sreelatha S, Devi A, Kallesh S, Sumaiah, Kavitha LB, et al. Study of association of lateral implantation of placenta with development of pre-eclampsia and its outcome. The New Indian J Obstet Gynaecol 2018; 5: 33–7. https://doi.org/10.21276/obgyn.2018.5.1.8
- Post covid calamity- Mucormycosis: An overview
Abstract Views :143 |
PDF Views:0
Authors
Affiliations
1 Anandi Pharmacy College, Kalambe Tarf Kale, Kolhapur., IN
1 Anandi Pharmacy College, Kalambe Tarf Kale, Kolhapur., IN
Source
Asian Journal of Research in Pharmaceutical Sciences, Vol 12, No 03 (2022), Pagination: 227-230Abstract
Corona virus disease (Covid-19) it had declared an emergency global pandemic1,2,3 that cause terrible effects on respiratory system and killing more than half billion lives.4,5,6 Diabetes has been reported as a risk factor for mucormycosis in 73.5% of cases in India.7 People with diabetes and obesity tend to develop more severe Covid-19 infections. This means they're more expected to take corticosteroids, which are frequently used to treat Covid-19. But the corticosteroids along with diabetes increase the risk of mucormycosis because it has been observed that peoples are affected with mucormycosis due to weekend immunity. Even a short course of steroid (5-14 days) results in mucormycosis.8 Mucormycosis, colloquially known as black fungus, is an infection from the mucormycetes group of fungi. The virus that causes Covid-19 can damage lung tissue and blood vessels, which could also increase susceptibility to different fungal infection. brain, causing headaches or seizures. So, damage to tissue and blood vessels from Covid-19 infection, treatment with corticosteroids, high background rates of diabetes in the population most brutally affected by the coronavirus are also getting affected by life threating fungal infection called as mucormycosis. Several methods have deferred the mortality but still have a challenge in curing mucorales.Keywords
Covid-19, mucormycosis, diabetes, corticosteroids, immunity.References
- Poonam Patil Critical Mobility And Inclination For Covid-19; 2020 9 (4) A; April 2020; Page No. 21803-21805.
- Princy Louis Palatty Sathyajith G. A review Pharmacotherapy for COVID-19. Asian Journal of Pharmacy and Pharmacology 2020; 6(5): 320-329.
- Mayur S. Jain, Shashikant D. Barhate. Favipiravir has been investigated for the treatment of life-threatening pathogens such as Ebola virus, Lassa virus, and now COVID-19: A Review. 10.5958/2231-5691.2021.00008.3.
- B. V. Naresh. A Review of the 2019 Novel Coronavirus (COVID-19) Pandemic. Asian J. Pharm. Res. 2020; 10(3):233-238.
- Archana B. Chavhan, Pavan S. Jadhav, Satish Shelke. COVID 19: Outbreak, Structure and Current therapeutic strategies. Asian J. Pharm. Tech. 2021; 11(1):76-83.
- Ali Adel dawood. Should we worry that the COVID-19 could be transmitted with the semen?. Asian J. Pharm. Res. 2020; 10(4):319-320.
- Patel, A.; Kaur, H.; Xess, I.; Michael, J.S.; Savio, J.; Rudramurthy, S.; Singh, R.; Shastri, P.; Umabala, P.;Sardana, R. A multicenter observational study on the epidemiology, risk factors, management and outcomes of mucormycosis in India. Clin. Microbiol. Infect. 2020, 26, 944.e9–944.e15. [CrossRef] [PubMed]
- Hoang K, Abdo T, Reinersman JM, Lu R, Higuita NIA. A case of invasive pulmonary mucormycosis resulting from short courses of corticosteroids in a well-controlled diabetic patient. Med Mycol Case Rep. 2020;29(1):22-24.
- Kubin CJ, McConville TH, Dietz D, et al. Characterization of Bacterial and Fungal Infections in Hospitalized Patients with COVID-19 and Factors Associated with Healthcare-associated Infections, Open Forum Infectious Diseases, 2021;,of ab 201, https://doi.org/10.1093/ofid/ofab201.
- Vankadari Venkata Sesha Satya Sagar1,Pallavi Yelne Mucormycosis in RT-PCR negative Covid 19 patient with newly diagnosed Diabetes Mellitus: A Case Report Asian Journal of Medical Sciences 2021 12 (7) 149-153.
- Ukpe Ajima A review of the Structure-Activity Relationships (SAR) of selected drugs with potential to be repurposed against SARS-COV-2 Asian Journal of Pharmacy and Pharmacology 2021; 7(1): 38-46.
- Song G, Liang G, Liu W. Fungal Co-infections Associated with Global COVID-19 Pandemic: A Clinical and Diagnostic Perspective from China. Mycopathologia. 2020 Aug;185(4):599-606.
- Savita Ramesh Shahani, Lokesh R. Shahani: COVID-19 infection: Does BCG Vaccine offers any protection. Asian Journal of Pharmacy and Pharmacology 2020; 6(3): 183-189.
- Baker RD. Pulmonary mucormycosis. Am J Pathol 1956; 32:287–313.
- Baker RD. Mucormycosis, a new disease? JAMA 1957; 163:805–8.
- B. Spellberg, T. J. Walsh, D. P. Kontoyiannis, J. J. Edwards Jr., and A. S. Ibrahim, “Recent advances in the management of mucormycosis: from bench to bedside,” Clinical Infectious Diseases, vol. 48, no. 12, pp. 1743–1751, 2009
- Richardson M. The ecology of the Zygomycetes and its impact on environmental exposureexternal icon. Clin Microbiol Infect. 2009 Oct;15 Suppl 5:2-9.
- Al-Ajam, MR, Bizri, AR, Mokhbat, J, Weedon, J, Lutwick, L. Mucormycosis in the Eastern Mediterranean: a seasonal diseaseexternal icon. Epidemiol Infect. 2006 Apr 134(2):341-6.
- Sivagnanam, S, Sengupta, DJ, Hoogestraat, D, Jain, R, Stednick, Z, Fredricks, DN, et al. Seasonal clustering of sinopulmonary mucormycosis in patients with hematologic malignancies at a large comprehensive cancer centerexternal icon. Antimicrob Resist Infect Control. 2017 November;6(1).
- Alvarez E, Sutton DA, Cano J, et al. Spectrum of zygomycete species identified in clinically significant specimens in the United States. J Clin Microbiol 2009; 47:1650–6
- Pasero D, Sanna S, Liperi C, Piredda D, Branca GP, Casadio L, et al. A challenging complication following SARS-CoV-2 infection: a case of pulmonary mucormycosis. Infect. 2020;
- Song Y, Qiao J, Giovanni G, Liu G, Yang H, Wu J, Chen J. Mucormycosis in renal transplant recipients: review of 174 reported casesexternal icon. BMC Infect Dis. 2017 Apr; 17(1): 283.
- Abdalla A, Adelmann D, Fahal A, Verbrugh H, Van Belkum A, De Hoog S. Environmental occurrence of Madurella mycetomatis, the major agent of human eumycetoma in Sudanexternal icon. J Clin Microbiol. 2002 Mar; 40(3): 1031–1036.
- Vallabhaneni S, Mody RK. Gastrointestinal mucormycosis in neonates: a reviewexternal icon. Current Fungal Infect Rep. 2015.
- Petrikkos G, Skiada A, Lortholary O, Roilides E, Walsh TJ, Kontoyiannis DP. Epidemiology and clinical manifestations of mucormycosisexternal icon. Clin Infect Dis. 2012 Feb;54 Suppl 1:S23-34.
- Rauthan P, Sharma DC, Mucormycosis: Pathogenesis, Diagnosis, and Management, Asian Journal of Pharmaceutical Research and Development. 2021; 9(3):144-153.
- Francis JR, Villanueva P, Bryant P, Blyth CC. Mucormycosis in children: review and recommendations for managementexternal icon. J Pediatric Infect Dis Soc. 2018 May 15;7(2):159-164.
- Bassetti M, Bouza E. Invasive mould infections in the ICU setting:complexities and solutions. J Antimicrob Chemother. 2017;72(1):i39–i47. doi:10.1093/jac/dkx032.
- Lin E, Moua T, Limper AH. Pulmonary mucormycosis: clinical features and outcomes. Infect. 2017;45(4):443–8. doi:10.1007/s15010-017-0991-6.
- Crum-Cianflone NF. Mucormycosis. eMedicine. 2008.
- Deutsch PG, Whittaker J, Prasad S. Invasive and non-invasive fungal rhinosinusitis—a review and update of the evidence, Medicina 55 (2019) 1–14.
- Ribes JA, Vanover-Sams CL, Baker DJ: Zygomycetes in human disease. Clin Microbiol Rev. 2000; 13(2): 236–301.
- Roden MM, Zaoutis TE, Buchanan WL, et al.: Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005; 41(5): 634–53.
- Baldin C, Ibrahim AS: Molecular mechanisms of mucormycosis-The bitter and the sweet. PLoS Pathog. 2017; 13(8): e1006408.
- Momeni AK, Roberts CC, Chew FS. Imaging of chronic and exotic sinonasal disease: review. AJR Am J Roentgenol 2007;189(6): S35–45. https://doi.org/10.2214/ AJR.07.7031
- Gokulshankar S, Mohanty BK COVID-19 AND BLACK FUNGUS. Asian Journal of Medicine and Health Sciences 2021 4 (1) 137-140.
- Deutsch PG, Whittaker J, Prasad S. Invasive and non-invasive fungal rhinosinusitis-a review and update of the evidence, Medicina 55 (2019) 1–14.
- Jeong, W.; Keighley, C.; Wolfe, R.; Lee, W.L.; Slavin, M.A.; Kong, D.C.M.; Chen, S.C.A. The epidemiology and clinical manifestations of mucormycosis: A systematic review and meta-analysis of case reports. Clin. Microbiol. Infect. 2019, 25, 26–34. [CrossRef] [PubMed]
- Skiada A, Lanternier F, Groll AH, Pagano L, Zimmerli S, Herbrecht R, Lortholary O, Petrikkos GL. Diagnosis and treatment of mucormycosis in patients with haematological malignancies: guidelines from the 3rd European Conference on Infections in Leukemia (ECIL 3). Haematological, 2013; 98(4): 492-504.